Business Standard
Home / India News / Marksans Pharma gets ANDA approval for Loratadine Liquid Capsules 10mg

Marksans Pharma gets ANDA approval for Loratadine Liquid Capsules 10mg

Image

Capital Market
Last Updated : Sep 27 2016 | 12:01 AM IST

From USFDA

Marksans Pharma announced that USFDA has granted approval for an Abbreviated New Drug Application (ANDA) for Loratadine Liquid Capsules 10 mg.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Also Read

Marksans Pharma gets ANDA approval for Metformin Hydrochloride ER Tablets

Marksans Pharma gets ANDA approval for Metformin Hydrochloride ER Tablets

Marksans Pharma gets USFDA clearance for allergy drug

Marksans Pharma gets USFDA clearance for allergy drug

Marksans Pharma gets USFDA nod for diabetes treatment tablets

Marksans Pharma gets USFDA nod for diabetes treatment tablets

Marksans Pharma surges after receiving USFDA approval for drug

Marksans Pharma surges after receiving USFDA approval for drug

Marksans Pharma standalone net profit declines 58.73% in the March 2016 quarter

Marksans Pharma standalone net profit declines 58.73% in the March 2016 quarter

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Sep 26 2016 | 11:12 AM IST

Explore News

Market LIVEMarket TodaySai Life Sciences IPOToss The Coin IPO AllotmentLatest News LIVEStocks To Watch TodayProcess to withdraw PF by ATMGold-Silver Price TodayIPO NewsBusiness Standard at 50
HOT STOCKS
TOP SECTIONS
KEY EVENTS
Copyrights © 2024 Business Standard Private Ltd. All rights reserved
LinkedIN Icon